|
1) Mandell, Douglas, Bennett's. In: Principles and Practice of Infectious Diseases. Churchill Livingston; 2004. p. 2607-9
|
|
|
|
|
2) Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis. 2006; 43 Suppl 2: S43-8
|
|
|
|
|
3) 後藤直正. MDRP発生のメカニズム. 医学のあゆみ. 2007; 221: 511-57
|
|
|
|
|
4) IDWR感染症の話. 多剤耐性緑膿菌. http://idsc.nih.go.jp/idwr/kansen/k02_g1/k02_17/k02_17.htm
|
|
|
|
|
|
5) 森兼啓太. 全国サーベイランスにみるMDRP発生動向. 感染対策ICTジャーナル. 2007; 2: 39-42
|
|
|
|
|
|
6) 石井良和. グラム陰性の耐性菌はなぜ増えた？Infection Control. 2007; 16: 624-9
|
|
|
|
|
|
7) Toleman MA, et al. Novel gene-capturing systems of the 21st century？ Microbiol Mol Biol Rev. 2006; 70: 296-316
|
|
|
|
|
8) Donskey CJ. Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli: Clin Infect Dis. 2006; 43(Suppl 2): S62-9
|
|
|
|
|
|
9) 柴田尚宏, 荒川宜親. MDRPの耐性機構. 臨床と微生物. 2007; 34: 83-8
|
|
|
|
|
|
10) 舘田一博. MDRP感染症の治療戦略. 感染対策ICTジャーナル. 2007; 2: 88-91
|
|
|
|
|
|
11) Harris AD, et al. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria？ Clin Infect Dis. 2006; 43 Suppl 2: S57-61
|
|
|
|
|
|
12) Bertrand X, et al. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med. 2001; 27: 1561-3
|
|
|
|
|
|
13) Bird J, et al. Multiply-resistant Klebsiella pneumoniae: failure of spread in community-based elderly care facilities. J Hosp Infect. 1998; 40: 243-7
|
|
|
|
|
|
14) CDC. Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006. http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf
|
|
|
|
|
|
15) 矢野邦夫. CDCガイドラインからみたMDRP感染対策. 臨床と微生物. 2007; 34: 143-50
|
|
|
|
|
|
16) 医療機関における院内感染対策マニュアル作成のための手引き(案) 070528 ver 4. 0: http://www.nih-janis.jp/manuduction2/｢手引き｣Ver%204.0.1.pd
|
|
|
|
|
|
17) Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis. 2006; 43(Suppl 2): S95-9
|
|
|
|
|
|
18) Tateda K, et al. ‘Break-point Checkerboard Plate'for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa. Scand J Infect Dis. 2006; 38: 268-72
|
|
|
|
|
|
19) 舘田一博. MDRPに対する抗菌薬併用療法感受性検査. 臨床と微生物. 2007; 34: 89-93
|
|
|
|
|
|
20) 飯沼由嗣. MDRPとコリスチン～海外文献にみる治療戦略. 感染対策ICTジャーナル. 2007; 2: 92-6
|
|
|
|
|
|
21) 松本哲哉. MDRP治療の方向性 基礎研究の立場から. 臨床と微生物. 2007; 34: 131-6
|
|
|
|
|